Pradaxa

Pradaxa and Xarelto are blood thinners and alternatives to warfarin that cause concerns for heart doctors.   

Recent findings reveal that patients with atrial fibrillation facing surgery could forgo their blood thinner therapy for a shorter time while on

Despite its stamp of approval from the FDA, some doctors are hesitant to prescribe a new blood thinner, dabigatran etexilate (

Pradaxa is proving to be as problematic as its predecessor, warfarin.

A study headed by Boehringer Ingelheim, the maker of Pradaxa, suggests a fixed dose of dabigatran therapy twice daily

The Institute for Safe Medication Practices listed Pradaxa (dabigatran) as the drug most commonly reported to the U.S.

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) reported Friday that the number of reported fatal bleedings associated with

A study conducted primarily by Boehringer Ingelheim, the maker of Pradaxa, suggests a fixed dose of dabigatran therapy

The first Pradaxa lawsuit was filed against drug manufacturer Boehringer Ingelheim last week on behalf of Bertha Bivens, who claims her mother died after suffering a gastrointestinal bleed that Pra

The first Pradaxa lawsuit was filed against drug manufacturer Boehringer Ingelheim last week on